• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[中高危单侧甲状腺乳头状癌对侧中央区淋巴结转移的危险因素分析及预测模型建立]

[Risk factors analysis and prediction model establishment of contralateral central lymph node metastasis in intermediate-to-high risk unilateral papillary thyroid carcinoma].

作者信息

Wang S S, Miao S C, Shan J L, Zhang D, Wang Q Q, Ni Q C, Fang J

机构信息

Department of General Surgery, Nantong University Affiliated Hospital, Nantong 226001, China Department of General Surgery, Suqian Hospital Affiliated to Xuzhou Medical University (Nanjing Gulou Hospital Group Suqian Hospital), Suqian 223800, China.

Medical School of Nantong University, Nantong 226001, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2024 Sep 24;104(36):3416-3421. doi: 10.3760/cma.j.cn112137-20240524-01180.

DOI:10.3760/cma.j.cn112137-20240524-01180
PMID:39307716
Abstract

To explore the risk factors of contralateral central lymph nodes (Cont-CLNs) metastasis in intermediate-to-high risk unilateral papillary thyroid carcinoma and establish a prediction model. The clinical data of 206 patients receiving thyroid cancer surgery at Nantong University Affiliated Hospital between January 2021 and June 2023 were retrospectively analyzed, including 50 males and 156 females, with an age of [(, )] 49.0(33.8, 57.0) years old. The risk factors of Cont-CLNs metastasis were screened by univariate analysis and multivariate logistic regression analysis. A nomogram was constructed for predicting Cont-CLNs metastasis in intermediate-to-high risk uPTC. The area under the receiver operating characteristic (ROC) curve(AUC), calibration curve, and decision curve analysis (DCA) were used to evaluate the model's predictive ability, accuracy, and clinical applicability, respectively. R language was used to randomly select 70% of the patients to establish a validation group for internal validation of the model. Patients were divided into a metastasis group (=56) and a non-metastasis group (=150) based on the occurrence of Cont-CLNs metastasis. The ages of the two groups were 39.0 (28.0, 56.8) years and 51.0 (38.8, 57.0) years, respectively. There were statistically significant differences in gender, maximum tumor diameter (>1 cm), ipsilateral central lymph nodes (Ipsi-CLNs) metastasis, number of Ipsi-CLNs metastases (≥4), and lateral lymph node metastasis and Cont-CLNs metastasis between the two groups (all <0.05). The results of multivariate logistic regression analyses showed that males(=2.926, : 1.063-8.051), maximum tumor diameter>1 cm(=4.471, : 1.344-14.877), and number of Ipsi-CLNs metastases≥4 (=5.011, : 1.815-13.834) were risk factors for Cont-CLNs metastasis (all <0.05). The AUC of the ROC curve, sensitivity, and specificity for predicting Cont-CLNs metastasis in intermediate-to-high risk uPTC by the prediction model in the modeling group were 0.821 (95%: 0.744-0.898), 82.5%, and 63.4%, respectively. In the internal validation group, the AUC of the ROC curve, sensitivity, and specificity for predicting Cont-CLNs metastasis in intermediate-to-high risk uPTC by the prediction model were 0.810 (95%: 0.717-0.902), 63.3%, and 83.7%, respectively. The calibration curves of the modeling group and the validation group showed that the model had good calibration ability. The DCA curves of the modeling group and the validation group indicated that the prediction model had good clinical adaptability. The prediction model constructed in this study has good predictive performance for Cont-CLNs metastasis in intermediate-to-high uPTC. When patient with intermediate-to-high risk uPTC is male, with maximum tumor diameter>1 cm, and the number of Ipsi-CLNs metastases≥4 should be alert to Cont-CLNs metastasis, and bilateral central lymph node dissection may be considered.

摘要

探讨中高风险单侧甲状腺乳头状癌对侧中央淋巴结(Cont-CLNs)转移的危险因素并建立预测模型。回顾性分析2021年1月至2023年6月在南通大学附属医院接受甲状腺癌手术的206例患者的临床资料,其中男性50例,女性156例,年龄为[(, )]49.0(33.8,57.0)岁。通过单因素分析和多因素logistic回归分析筛选Cont-CLNs转移的危险因素。构建预测中高风险甲状腺乳头状癌(uPTC)患者Cont-CLNs转移的列线图。采用受试者操作特征(ROC)曲线下面积(AUC)、校准曲线和决策曲线分析(DCA)分别评估模型的预测能力、准确性和临床适用性。使用R语言随机选取70%的患者建立验证组对模型进行内部验证。根据Cont-CLNs转移情况将患者分为转移组(=56)和非转移组(=150)。两组患者年龄分别为39.0(28.0,56.8)岁和51.0(38.8,57.0)岁。两组患者在性别、最大肿瘤直径(>1 cm)、同侧中央淋巴结(Ipsi-CLNs)转移、Ipsi-CLNs转移数量(≥4个)、侧方淋巴结转移及Cont-CLNs转移方面差异均有统计学意义(均<0.05)。多因素logistic回归分析结果显示,男性(=2.926,: 1.063 - 8.051)、最大肿瘤直径>1 cm(=4.471,: 1.344 - 14.877)及Ipsi-CLNs转移数量≥4个(=5.011,: 1.815 - 13.834)是Cont-CLNs转移的危险因素(均<0.05)。建模组预测模型预测中高风险uPTC患者Cont-CLNs转移的ROC曲线AUC、灵敏度和特异度分别为0.821(95%: 0.744 - 0.898)、82.5%和63.4%。在内部验证组中,预测模型预测中高风险uPTC患者Cont-CLNs转移的ROC曲线AUC、灵敏度和特异度分别为0.810(95%: 0.717 - 0.902)、63.3%和83.7%。建模组和验证组的校准曲线显示模型具有良好的校准能力。建模组和验证组的DCA曲线表明预测模型具有良好的临床适用性。本研究构建的预测模型对中高风险uPTC患者Cont-CLNs转移具有良好的预测性能。当中高风险uPTC患者为男性、最大肿瘤直径>1 cm且Ipsi-CLNs转移数量≥4个时,应警惕Cont-CLNs转移,可考虑行双侧中央淋巴结清扫术。

相似文献

1
[Risk factors analysis and prediction model establishment of contralateral central lymph node metastasis in intermediate-to-high risk unilateral papillary thyroid carcinoma].[中高危单侧甲状腺乳头状癌对侧中央区淋巴结转移的危险因素分析及预测模型建立]
Zhonghua Yi Xue Za Zhi. 2024 Sep 24;104(36):3416-3421. doi: 10.3760/cma.j.cn112137-20240524-01180.
2
Prediction Model of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma.甲状腺乳头状癌颈淋巴结转移预测模型。
Cancer Control. 2024 Jan-Dec;31:10732748241295347. doi: 10.1177/10732748241295347.
3
Nomogram model based on preoperative clinical characteristics of unilateral papillary thyroid carcinoma to predict contralateral medium-volume central lymph node metastasis.基于单侧甲状腺乳头状癌术前临床特征的列线图模型预测对侧中等体积中央淋巴结转移。
Front Endocrinol (Lausanne). 2024 Feb 12;14:1271446. doi: 10.3389/fendo.2023.1271446. eCollection 2023.
4
Single-center external validation and reconstruction of multiple predictive models for skip lateral lymph node metastasis in papillary thyroid carcinoma.单中心外部验证及多预测模型在甲状腺乳头状癌跳跃侧颈部淋巴结转移中的重建。
Front Endocrinol (Lausanne). 2024 Aug 23;15:1366679. doi: 10.3389/fendo.2024.1366679. eCollection 2024.
5
Development of a nomogram for prediction of central lymph node metastasis of papillary thyroid microcarcinoma.建立预测甲状腺微小乳头状癌中央区淋巴结转移的列线图。
BMC Cancer. 2024 Feb 20;24(1):235. doi: 10.1186/s12885-024-12004-3.
6
Risk prediction for central lymph node metastasis in isolated isthmic papillary thyroid carcinoma by nomogram: A retrospective study from 2010 to 2021.基于列线图的孤立峡部型甲状腺微小乳头状癌中央区淋巴结转移风险预测:一项 2010 年至 2021 年的回顾性研究。
Front Endocrinol (Lausanne). 2023 Jan 17;13:1098204. doi: 10.3389/fendo.2022.1098204. eCollection 2022.
7
Predictors and a Prediction Model for Central Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma (cN0).预测甲状腺乳头状癌(cN0)中央颈部淋巴结转移的预测因子和预测模型。
Front Endocrinol (Lausanne). 2022 Jan 27;12:789310. doi: 10.3389/fendo.2021.789310. eCollection 2021.
8
Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.甲状腺乳头状癌侧颈淋巴结跳跃转移的危险因素及预测模型。
World J Surg. 2020 May;44(5):1498-1505. doi: 10.1007/s00268-019-05332-0.
9
The model for predicting the central lymph node metastasis in cN0 papillary thyroid microcarcinoma with Hashimoto's thyroiditis.预测伴有桥本甲状腺炎的 cN0 期甲状腺微小乳头状癌中央区淋巴结转移的模型。
Front Endocrinol (Lausanne). 2024 Apr 30;15:1330896. doi: 10.3389/fendo.2024.1330896. eCollection 2024.
10
Machine learning algorithms for identifying contralateral central lymph node metastasis in unilateral cN0 papillary thyroid cancer.用于识别单侧 cN0 甲状腺乳头状癌中央淋巴结转移的机器学习算法。
Front Endocrinol (Lausanne). 2024 May 10;15:1385324. doi: 10.3389/fendo.2024.1385324. eCollection 2024.